Follow The Filings

SNX TD Synnex Corporation

Information Technology, filed as TD SYNNEX CORPORATION (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Bought by 1 manager in 2026 Q2, sold by 4

  • 6 Owners
  • #244
  • Max 26.4%
  • Master 0.08%
  • $1.4B
  • 1 new 4 reduce 1 small

In 2026 Q2, 1 manager opened a position and 4 trimmed.

Who owns this now

Largest portfolio weights among holders, up to 26.4% (Abrams Bison, Abrams Bison Investments). Not free-float ownership.

  1. Abrams Bison Reduce 26.4%
  2. Glenn Greenberg Reduce 8.4%
  3. Eric Khrom Reduce 6.8%
  4. Lyrical Asset Management Reduce 3.9%
  5. David Einhorn Reduce 2.6%
  6. Lee Ainslie New 0.01%

Who owns SNX

Sorted by value, long equity only, as of 2026 Q2.

History
Abrams Bison, Abrams Bison Investments 26.4% Reduce −18.9% 2,021,764 $540M History
Glenn Greenberg, Brave Warrior Advisors 8.4%, was 12.8% Reduce −52.8% 1,441,630 $385M History
Lyrical Asset Management 3.9% Small trim −1.6% 1,157,217 $309M History
David Einhorn, DME Capital Management 2.6% Reduce −20.5% 381,042 $102M History
Eric Khrom, Khrom Capital Management 6.8%, was 9.3% Reduce −49.7% 303,514 $81M History
Lee Ainslie, Maverick Capital 0.01% New 0.01% 2,317 $619K History

6 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by SNX's executives, directors and 10% owners in the last 12 months, from their Form 4s

All SNX insider trades
  • None no insider bought on the open market
  • $16.8M sold by 7 insiders outside a trading plan
  • $26.2M sold by 4 insiders under 10b5-1 plans
  1. Alim Dhanji Chief Human Resources Officer
    Sale
    $910K 3,775 shares at $241.01 24% of stake
    Traded Oct 22 Filed Oct 23
    ↗
  2. Dennis Polk Chair
    Sale
    $994K 3,955 shares at $251.27 16% of stake
    Traded Oct 21 Filed Oct 22
    ↗
  3. Reyna Thompson President, North America
    Planned sale
    $604K 2,433 shares at $248.45 15% of stake
    Traded Oct 20 Filed Oct 21
    ↗
  4. Dennis Polk Chair
    Planned sale
    $629K 2,500 shares at $251.76 3.6% of stake
    Traded Oct 15 Filed Oct 15
    ↗
  5. Dennis Polk Chair
    Planned sale
    $660K 2,500 shares at $264.19 3.5% of stake
    Traded Sep 15 Filed Sep 16
    ↗
  6. Dennis Polk Chair
    Planned sale
    $653K 2,500 shares at $261.21 3.4% of stake
    Traded Aug 17 Filed Aug 18
    ↗
  7. Richard T Hume Director
    Planned sale
    $1.3M 5,000 shares at $262.21 27% of stake
    Traded Aug 5 Filed Aug 6
    ↗
  8. Ann F Vezina Director
    Sale
    $326K 1,273 shares at $256.05 18% of stake
    Traded Jul 31 Filed Jul 31
    ↗
  9. Dennis Polk Chair
    Planned sale
    $624K 2,500 shares at $249.67 3.3% of stake
    Traded Jul 15 Filed Jul 16
    ↗
  10. Richard T Hume Director
    Planned sale
    $1.2M 5,000 shares at $242.97 21% of stake
    Traded Jul 6 Filed Jul 7
    ↗
  11. Dennis Polk Chair
    Sale
    $2.7M 10,000 shares at $268.48 31% of stake
    Traded Jun 30 Filed Jul 1
    ↗
  12. Dennis Polk Chair
    Sale
    $4M 15,000 shares at $265.39 40% of stake
    Traded Jun 29 Filed Jun 30
    ↗
  13. Dennis Polk Chair
    Planned sale
    $711K 2,500 shares at $284.33 3.2% of stake
    Traded Jun 15 Filed Jun 16
    ↗
  14. Richard T Hume Director
    Planned sale
    $1.4M 5,000 shares at $280.38 18% of stake
    Traded Jun 2 Filed Jun 3
    ↗
  15. Richard T Hume Director
    Planned sale
    $1.1M 5,000 shares at $229.54 15% of stake
    Traded May 18 Filed May 18
    ↗

Also filed in the last 12 months, not counted as buying or selling: 31 share withholdings for taxes, 21 stock grants, and 12 option exercises.

Congress

No member of Congress reported trading SNX in the last three years. 1 member listed it in 2025 annual reports.

All Congress trades

SEC filings

Recent issuer filings from EDGAR, 11 shown.

Filed Form Detail Links
SCHEDULE 13G/A — Filing Doc
10-Q Filing Doc
8-K 1.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 5.02,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 5.02,9.01 Filing Doc
10-Q Filing Doc
8-K 1.01,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 3 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $57.56B $58.45B $62.51B
Gross profit $3.96B $3.98B $4.37B
Gross margin * 6.9% 6.8% 7.0%
Net income $626.91M $689.09M $827.66M
Net margin * 1.1% 1.2% 1.3%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $20.08B $21.32B $25.29B
Total non-current assets * $9.33B $8.95B $8.96B
Total assets $29.41B $30.27B $34.25B
Total current liabilities $16.74B $17.22B $20.96B
Total non-current liabilities * $4.49B $5.02B $4.84B
Total equity $8.18B $8.04B $8.45B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $1.41B $1.22B $1.53B
Cash from investing -$156.41M -$193.84M -$221.17M
Cash from financing -$785.88M -$953.1M -$32.87M
Net change in cash $0.511B $0.026B $1.38B

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.